With the introduction of percutaneous options, the role of surgery in the repair of dysfunctional tricuspid valves is being reevaluated in an effort to reduce the risk for end-stage disease. In the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Transcatheter tricuspid valve replacement using the ...

Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive ...

The Global Tricuspid Valve Repair Market is expected to reach a US$2.5 billion market by 2028. Rise in the incidence of ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first transcatheter tricuspid valve replacement system. The system is indicated for ...

SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had “meaningful” improvements in ...

NEW YORK CITY -- Recent device approvals officially put transcatheter tricuspid valve intervention (TTVI) on the map for symptomatic severe tricuspid regurgitation (TR), though workforce challenges ...

Henry Ford Health cardiologists are the first to offer new Tri-Clip procedure to patients for whom open-heart surgery isn’t an option A breakthrough in treating tricuspid regurgitation, or TR, is ...

Stopping leaks in the heart’s tricuspid valve has been a notoriously tricky fix, but, now, the FDA is handing out its second approval for a dedicated, minimally invasive therapy in as many months.

LONDON, England—Many patients undergoing tricuspid transcatheter edge-to-edge repair (T-TEER) in the real world may bear little resemblance to those treated in the randomized TRILUMINATE trial, ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced ...

Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...